Using exercise endpoints in heart failure trials: design considerations
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 1, 1996
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Angiotensin-Converting Enzyme Inhibitors (MeSH)
- Cardiotonic Agents (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Exercise Test (MeSH)
- Heart Failure (MeSH)
- Humans (MeSH)
- Randomized Controlled Trials as Topic (MeSH)
- Reproducibility of Results (MeSH)
- Treatment Outcome (MeSH)
- Vasodilator Agents (MeSH)
published in
- European Heart Journal Journal